PMID: 11328217May 1, 2001Paper

The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study

Acta Obstetricia Et Gynecologica Scandinavica
European Atosiban Study Group

Abstract

To compare the efficacy and safety of atosiban and terbutaline for the inhibition of preterm labor. Two hundred and forty-nine women diagnosed with preterm labor at 23-33 weeks of gestation were enrolled of whom 245 women received treatment, 116 with atosiban and 129 with terbutaline. At randomization, women were stratified by gestational age (< or =28 weeks and >28 weeks). Atosiban (iv bolus dose of 6.75 mg, then 300 microg/min for 3 h and 100 microg/min thereafter) and terbutaline (5-20 microg/min) were administered by iv infusion for 13-18 h. Re-treatment with study drug or an alternative tocolytic agent was allowed. Tocolytic effectiveness was assessed in terms of the number of women undelivered after 48 hours and 7 days and efficacy and tolerability in terms of the number of women remaining undelivered and not requiring alternative tocolytic therapy after 48 hours and 7 days of starting therapy. Safety was assessed in terms of maternal side effects and neonatal morbidity. Tocolytic effectiveness at 48 hours was 86.1% vs 85.3%; p=0.783, and after 7 days it was 76.5% vs 67.4%; p=0.067, in the atosiban and terbutaline groups, respectively. Tocolytic efficacy and tolerability after 48 hours was 72.2% vs 68.2%; p=0.51 and after...Continue Reading

References

Jul 30, 1992·The New England Journal of Medicine·K J Leveno, F G Cunningham
Sep 1, 1992·American Journal of Obstetrics and Gynecology·B A ArmsonE K Main
Mar 11, 1992·Southern Medical Journal·K J MoiseR J Carpenter
Jul 30, 1992·The New England Journal of Medicine·UNKNOWN Canadian Preterm Labor Investigators Group
Jun 1, 1989·American Journal of Obstetrics and Gynecology·M M TaslimiC N Herrick
Dec 1, 1989·British Journal of Obstetrics and Gynaecology·N A Watson, B Morgan
Aug 1, 1989·American Journal of Obstetrics and Gynecology·H A Hadi, S J Albazzaz
Sep 1, 1989·Clinical Nuclear Medicine·J SylvesterR A Holmes
Mar 1, 1988·British Journal of Obstetrics and Gynaecology·J F KingI Chalmers
Nov 1, 1988·AJR. American Journal of Roentgenology·M MilosK Brown
Jun 1, 1985·Obstetrics and Gynecology·T L GrossN J Kazzi
Nov 15, 1984·American Journal of Obstetrics and Gynecology·A R FuchsM S Soloff
Jan 1, 1983·Journal of Perinatal Medicine·R F LamontM G Elder
Nov 1, 1995·American Journal of Obstetrics and Gynecology·H Y HowJ A Spinnato
Sep 1, 1995·American Journal of Obstetrics and Gynecology·T M GoodwinM L Holland
Apr 1, 1995·American Journal of Obstetrics and Gynecology·G J ValenzuelaM L Holland
Aug 1, 1994·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Z J HagayA Weissman
Apr 1, 1993·American Journal of Obstetrics and Gynecology·K HigbyC J Pauerstein
Oct 1, 1993·British Journal of Obstetrics and Gynaecology·R F Lamont
Feb 1, 1994·American Journal of Obstetrics and Gynecology·T M GoodwinR Merriman
Oct 1, 1993·American Journal of Obstetrics and Gynecology·B V ParillaM L Socol
Jul 1, 1993·American Journal of Obstetrics and Gynecology·D R Hudgens, S E Conradi
Jan 1, 1993·American Journal of Obstetrics and Gynecology·R L CopperS P Cliver
Apr 1, 1996·American Journal of Perinatology·T M GoodwinR Lane
Jul 1, 1996·British Journal of Obstetrics and Gynaecology·C A HolleboomM J Keirse
Oct 1, 1996·American Journal of Obstetrics and Gynecology·R LewisB M Sibai
Feb 1, 1997·American Journal of Perinatology·K D WenstromJ Niebyl
Aug 1, 1997·American Journal of Perinatology·H L BrownA M Golichowski
Nov 25, 1997·American Journal of Obstetrics and Gynecology·D A GuinnJ C Hauth
Jun 24, 1998·British Journal of Obstetrics and Gynaecology·G A MaconesD A Asch
Oct 30, 2004·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R M Cole, R F Lamont
Nov 1, 2009·Journal of Evidence-based Medicine

❮ Previous
Next ❯

Citations

Mar 6, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·Jayanta ChatterjeeSteve Thornton
Nov 17, 2010·European Journal of Clinical Pharmacology·Isabelle FabryLuc Van Bortel
Apr 22, 2008·Expert Opinion on Pharmacotherapy·K Y Ronald Kam, Ronald F Lamont
May 16, 2007·Expert Opinion on Investigational Drugs·Jens Lyndrup, Ronald F Lamont
Jul 24, 2012·Reproductive Biomedicine Online·Vuong Thi Ngoc LanHo Manh Tuong
Mar 1, 2012·Obstetrics and Gynecology Clinics of North America·Adi AbramoviciSheri M Jenkins
Dec 7, 2010·Reproductive Biomedicine Online·Piotr Pierzynski
Feb 5, 2005·Seminars in Fetal & Neonatal Medicine·P N Tara, S Thornton
Mar 29, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S G Oei
Mar 1, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jerry ChanNicholas M Fisk
Jul 27, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M KashanianM Soltanzadeh
Jan 9, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·R F Lamont
Oct 2, 2007·American Journal of Obstetrics and Gynecology·Edward HayesJason Baxter
Jun 25, 2014·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·L DriulD Marchesoni
Aug 28, 2004·Expert Opinion on Pharmacotherapy·Sheila A Doggrell
Aug 22, 2009·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·François-Xavier DuchateauJean Mantz
Dec 3, 2009·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Felice Petraglia, Gerard H A Visser
Feb 26, 2010·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Khalid KhanBryan Beattie
Mar 27, 2002·Current Opinion in Obstetrics & Gynecology·Vasso Terzidou, Phillip R Bennett
Aug 23, 2002·Acta Obstetricia Et Gynecologica Scandinavica·Peter Husslein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.